These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 5729205)

  • 1. Prevention of abdominal metastases after intraperitoneal injection of Yoshida ascites cells: use of a new colloidal 32P-chromic phosphate.
    Anghileri LJ; Dogàn EB
    J Nucl Med; 1968 Nov; 9(11):562-6. PubMed ID: 5729205
    [No Abstract]   [Full Text] [Related]  

  • 2. Colloidal chromic phosphate: its biological behaviour.
    Anghileri LJ
    Nucl Med (Stuttg); 1967 Oct; 6(3):321-30. PubMed ID: 6059880
    [No Abstract]   [Full Text] [Related]  

  • 3. The uptake of 51-Cr-chromic-beta-glycerophosphate by Yoshida tumors.
    Anghileri LJ
    Oncology; 1967; 21(4):275-82. PubMed ID: 5587637
    [No Abstract]   [Full Text] [Related]  

  • 4. Distribution and tissue dose of intraperitoneally administered radioactive chromic phosphate (32P) in New Zealand white rabbits.
    Leichner PK; Rosenshein NB; Leibel SA; Order SE
    Radiology; 1980 Mar; 134(3):729-34. PubMed ID: 7355227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival and frequency of pulmonary metastases in rats with implanted and removed primary Yoshida sarcoma after treatment with E-aminocaproic acid and sintrom.
    Szacki J; Lawiński M; Grzebieluch M
    Arch Immunol Ther Exp (Warsz); 1973; 21(5):763-6. PubMed ID: 4793160
    [No Abstract]   [Full Text] [Related]  

  • 6. [Brachytherapy of solid tumors. Use of chromic phosphate colloid].
    Zubillaga M; Boccio J; Nicolini J; Ughetti R; Lanari E; Caro R
    Acta Physiol Pharmacol Ther Latinoam; 1997; 47(3):179-85. PubMed ID: 9410223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on colloidal chromic phosphate: an improved method of preparation and in situ precipitation by injection of papain.
    Anghileri LJ
    Int J Appl Radiat Isot; 1968 Apr; 19(4):415-20. PubMed ID: 5650887
    [No Abstract]   [Full Text] [Related]  

  • 8. Adjuvant internal hepatic radiotherapy using colloidal 32P chromic phosphate in colorectal cancer.
    Kim JY; Bom HS; Kim YJ; Choi W
    Radiat Med; 1990; 8(6):246-9. PubMed ID: 2093946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ionic phosphate injections on the colloidal chromic radiophosphate (32P) deposited in the bone.
    Anghileri LJ
    Naturwissenschaften; 1965 Sep; 52(18):516. PubMed ID: 5881541
    [No Abstract]   [Full Text] [Related]  

  • 10. Synoviorthesis with 32P-colloidal chromic phosphate in rheumatoid arthritis--clinical, histopathologic and arthrographic changes.
    Onetti CM; Gutiérrez E; Hliba E; Aguirre CR
    J Rheumatol; 1982; 9(2):229-38. PubMed ID: 7097682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Various methods of applying cytostatic agents in the form of shock therapy in the prevention of metastasis and relapse of tumors].
    Shmidt D
    Eksp Khir Anesteziol; 1969; 14(1):36-41. PubMed ID: 5378919
    [No Abstract]   [Full Text] [Related]  

  • 12. Observations on the intraperitoneal distribution of chromic phosphate (32P) suspension for intraperitoneal therapy.
    Sullivan DC; Harris CC; Currie JL; Wilkinson RH; Creasman WT
    Radiology; 1983 Feb; 146(2):539-41. PubMed ID: 6849103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracavitary chromic phosphate (32P) colloidal suspension therapy.
    Jackson GL; Blosser NM
    Cancer; 1981 Dec; 48(12):2596-8. PubMed ID: 7306919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Synoviorthesis of the knee joint with 32P-chromic phosphate (author's transl)].
    Galeazzi H; Rösler H; Ramel P; Carnes H
    Nuklearmedizin; 1979 Dec; 18(5):223-5. PubMed ID: 547247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraperitoneal radioactive chromic phosphate (P32) in the treatment of ovarian cancer.
    Powell JL; Kirchner AB
    J Med Assoc Ga; 1984 Jan; 73(1):21-5. PubMed ID: 6707541
    [No Abstract]   [Full Text] [Related]  

  • 16. Astatine-211--tellurium radiocolloid cures experimental malignant ascites.
    Bloomer WD; McLaughlin WH; Neirinckx RD; Adelstein SJ; Gordon PR; Ruth TJ; Wolf AP
    Science; 1981 Apr; 212(4492):340-1. PubMed ID: 7209534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of prolonged administration of -aminocaproic acid and sintrom on metastases of Yoshida sarcoma to the lungs in rats.
    Lawiński M; Szacki J; Grzebieluch M; Kotschy M
    Arch Immunol Ther Exp (Warsz); 1971; 19(4):523-32. PubMed ID: 5095071
    [No Abstract]   [Full Text] [Related]  

  • 18. Five and ten year estimated survival and disease-free rates after intraperitoneal chromic phosphate; stage I ovarian adenocarcinoma.
    Piver MS; Lele SB; Bakshi S; Parthasarathy KL; Emrich LJ
    Am J Clin Oncol; 1988 Oct; 11(5):515-9. PubMed ID: 3177251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on two variant strains of Yoshida sarcoma characterized by island formation in ascites.
    Ishidate M; Isaka H
    Gan; 1966 Aug; 57(4):413-26. PubMed ID: 5338890
    [No Abstract]   [Full Text] [Related]  

  • 20. The use of 99mTc-sulfur colloid to assess the distribution of 32P-chromic phosphate.
    Tully TE; Goldberg ME; Loken MK
    J Nucl Med; 1974 Mar; 15(3):190-1. PubMed ID: 4813227
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.